These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 23994236

  • 1. Amyloid-β₂₅₋₃₅ induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2.
    Isono T, Yamashita N, Obara M, Araki T, Nakamura F, Kamiya Y, Alkam T, Nitta A, Nabeshima T, Mikoshiba K, Ohshima T, Goshima Y.
    Neurosci Res; 2013 Nov; 77(3):180-5. PubMed ID: 23994236
    [Abstract] [Full Text] [Related]

  • 2. Proteome and behavioral alterations in phosphorylation-deficient mutant Collapsin Response Mediator Protein2 knock-in mice.
    Nakamura H, Takahashi-Jitsuki A, Makihara H, Asano T, Kimura Y, Nakabayashi J, Yamashita N, Kawamoto Y, Nakamura F, Ohshima T, Hirano H, Tanaka F, Goshima Y.
    Neurochem Int; 2018 Oct; 119():207-217. PubMed ID: 29758318
    [Abstract] [Full Text] [Related]

  • 3. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
    Uchida Y, Ohshima T, Sasaki Y, Suzuki H, Yanai S, Yamashita N, Nakamura F, Takei K, Ihara Y, Mikoshiba K, Kolattukudy P, Honnorat J, Goshima Y.
    Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
    [Abstract] [Full Text] [Related]

  • 4. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression.
    Cole AR, Noble W, van Aalten L, Plattner F, Meimaridou R, Hogan D, Taylor M, LaFrancois J, Gunn-Moore F, Verkhratsky A, Oddo S, LaFerla F, Giese KP, Dineley KT, Duff K, Richardson JC, Yan SD, Hanger DP, Allan SM, Sutherland C.
    J Neurochem; 2007 Nov; 103(3):1132-44. PubMed ID: 17683481
    [Abstract] [Full Text] [Related]

  • 5. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
    Rammes G, Gravius A, Ruitenberg M, Wegener N, Chambon C, Sroka-Saidi K, Jeggo R, Staniaszek L, Spanswick D, O'Hare E, Palmer P, Kim EM, Bywalez W, Egger V, Parsons CG.
    Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
    [Abstract] [Full Text] [Related]

  • 6. Regulation of CRMP2 by Cdk5 and GSK-3β participates in sevoflurane-induced dendritic development abnormalities and cognitive dysfunction in developing rats.
    Liao Z, Huang Z, Li J, Li H, Miao L, Liu Y, Zhang J, Xu Y, Li Y.
    Toxicol Lett; 2021 May 01; 341():68-79. PubMed ID: 33548343
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
    Jing W, Guo F, Cheng L, Zhang JF, Qi JS.
    Neurosci Lett; 2009 Feb 06; 450(3):306-10. PubMed ID: 19059464
    [Abstract] [Full Text] [Related]

  • 10. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N, Toba J, Yoshii A, Nikkuni M, Ohshima T.
    J Neurosci Res; 2016 Jan 06; 94(1):15-26. PubMed ID: 26400044
    [Abstract] [Full Text] [Related]

  • 11. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
    Santos DB, Peres KC, Ribeiro RP, Colle D, dos Santos AA, Moreira EL, Souza DO, Figueiredo CP, Farina M.
    Exp Neurol; 2012 Feb 06; 233(2):767-75. PubMed ID: 22173317
    [Abstract] [Full Text] [Related]

  • 12. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH, Xu LJ, Liu ZQ, Wei B, Yang YJ, Xu GG, Yin XP, Wang W.
    Behav Brain Res; 2016 Sep 15; 311():309-321. PubMed ID: 27233830
    [Abstract] [Full Text] [Related]

  • 13. Simvastatin treatment preserves synaptic plasticity in AβPPswe/PS1dE9 mice.
    Métais C, Brennan K, Mably AJ, Scott M, Walsh DM, Herron CE.
    J Alzheimers Dis; 2014 Sep 15; 39(2):315-29. PubMed ID: 24164738
    [Abstract] [Full Text] [Related]

  • 14. Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo.
    Zhang JF, Qi JS, Qiao JT.
    Neurobiol Learn Mem; 2009 Mar 15; 91(3):226-34. PubMed ID: 19061963
    [Abstract] [Full Text] [Related]

  • 15. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O.
    Ann Neurol; 2004 Jun 15; 55(6):801-14. PubMed ID: 15174014
    [Abstract] [Full Text] [Related]

  • 16. Involvement of WAVE accumulation in Abeta/APP pathology-dependent tangle modification in Alzheimer's disease.
    Takata K, Kitamura Y, Nakata Y, Matsuoka Y, Tomimoto H, Taniguchi T, Shimohama S.
    Am J Pathol; 2009 Jul 15; 175(1):17-24. PubMed ID: 19497998
    [Abstract] [Full Text] [Related]

  • 17. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
    Srivareerat M, Tran TT, Alzoubi KH, Alkadhi KA.
    Biol Psychiatry; 2009 Jun 01; 65(11):918-26. PubMed ID: 18849021
    [Abstract] [Full Text] [Related]

  • 18. Aβ-AGE aggravates cognitive deficit in rats via RAGE pathway.
    Chen C, Li XH, Tu Y, Sun HT, Liang HQ, Cheng SX, Zhang S.
    Neuroscience; 2014 Jan 17; 257():1-10. PubMed ID: 24188791
    [Abstract] [Full Text] [Related]

  • 19. Changes in the expression of collapsin response mediator protein-2 during synaptic plasticity in the mouse hippocampus.
    Kadoyama K, Matsuura K, Nakamura-Hirota T, Takano M, Otani M, Matsuyama S.
    J Neurosci Res; 2015 Nov 17; 93(11):1684-92. PubMed ID: 26250894
    [Abstract] [Full Text] [Related]

  • 20. The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation.
    Hu WY, He ZY, Yang LJ, Zhang M, Xing D, Xiao ZC.
    Br J Pharmacol; 2015 May 17; 172(9):2273-85. PubMed ID: 25521332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.